Evidence map›Paper›PMID 42625217›Full record

ArticleJournal of experimental & clinical cancer research : CR2026

Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma.

Barbara Montico, Giorgio Giurato, Roberto Guerrieri, Francesca Colizzi, Annamaria Salvati, Giovanni Nassa, Jessica Lamberti, Domenico Memoli, Patrizia Sabatelli, Marina Comelli and 14 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Barbara Montico *Immunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Giorgio Giurato *Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', Laboratory of Molecular Medicine and Genomics, University of Salerno, Baronissi, Italy.
Roberto GuerrieriImmunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Francesca ColizziImmunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Annamaria SalvatiDepartment of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', Laboratory of Molecular Medicine and Genomics, University of Salerno, Baronissi, Italy.
Giovanni NassaDepartment of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', Laboratory of Molecular Medicine and Genomics, University of Salerno, Baronissi, Italy.
Jessica LambertiImmunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Domenico MemoliDepartment of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', Laboratory of Molecular Medicine and Genomics, University of Salerno, Baronissi, Italy.
Patrizia SabatelliCNR-Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", Unit of Bologna, Bologna, Italy.
Marina ComelliDepartment of Medicine, University of Udine, Udine, Italy.
Arianna BellazzoImmunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Albina FejzaMolecular Oncology Unit, Centro Di Riferimento Oncologico Di Aviano (CRO), IRCCS, Aviano, Italy.
Lucrezia CamiciaMolecular Oncology Unit, Centro Di Riferimento Oncologico Di Aviano (CRO), IRCCS, Aviano, Italy.
Lorena BabociImmunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Michele Dal BoExperimental and Clinical Pharmacology Unit, Centro Di Riferimento Oncologico Di Aviano (CRO), IRCCS, Aviano, PN, Italy.
Alessia CovreUniversity of Siena, Siena, Italy.
Tuula A NymanDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Alessandro WeiszDepartment of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', Laboratory of Molecular Medicine and Genomics, University of Salerno, Baronissi, Italy.
Agostino SteffanImmunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Michele MaioUniversity of Siena, Siena, Italy.
Luca SigalottiOncogenetics and Functional Oncogenomics Unit, Centro Di Riferimento Oncologico Di Aviano (CRO), IRCCS, Aviano, Italy.
Maurizio MongiatMolecular Oncology Unit, Centro Di Riferimento Oncologico Di Aviano (CRO), IRCCS, Aviano, Italy.
Eva Andreuzzi *Obstetrics and Gynecology, Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Trieste, 34137, Italy.
Elisabetta Fratta *Immunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy. efratta@cro.it.ORCID http://orcid.org/0000-0002-7472-8841

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42625217
PMCPMC13495281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.